Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer

被引:113
作者
Barnett, Daniel H. [2 ,4 ]
Sheng, Shubin [1 ]
Charn, Tze Howe [3 ]
Waheed, Abdul [5 ]
Sly, William S. [5 ]
Lin, Chin-Yo [6 ,7 ]
Liu, Edison T. [7 ]
Katzenellenbogen, Benita S. [1 ,2 ,4 ]
机构
[1] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA
[3] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA
[4] Univ Illinois, Coll Med, Urbana, IL 61801 USA
[5] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63103 USA
[6] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA
[7] Genome Inst Singapore, Singapore, Singapore
关键词
D O I
10.1158/0008-5472.CAN-07-6151
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of carbonic anhydrase XII (CA12), a gene that encodes a zinc metalloenzyme responsible for acidification of the microenvironment of cancer cells, is highly correlated with estrogen receptor alpha (ER alpha) in human breast tumors. Here, we show that CA12 is robustly regulated by estrogen via ER alpha in breast cancer cells, and that this regulation involves a distal estrogen-responsive enhancer region. Upon the addition of estradiol, ER alpha binds directly to this distal enhancer in vivo, resulting in the recruitment of RNA polymerase II and steroid receptor coactivators SRC-2 and SRC-3, and changes in histone acetylation. Mutagenesis of an imperfect estrogen-responsive element within this enhancer region abolishes estrogen-dependent activity, and chromosome conformation capture and chromatin immunoprecipitation assays show that this distal enhancer communicates with the transcriptional start site of the CA12 gene via intrachromosomal looping upon hormone treatment. This distal enhancer element is observed in the homologous mouse genomic sequence, and the expression of the mouse homologue, Car12, is rapidly and robustly stimulated by estradiol in the mouse uterus in vivo, suggesting that the ER regulation of CA12 is mechanistically and evolutionarily conserved. Our findings highlight the crucial role of ER in the regulation of the CA12 gene, and provide insight into the transcriptional regulatory mechanism that accounts for the strong association of CA12 and ER in human breast cancers.
引用
收藏
页码:3505 / 3515
页数:11
相关论文
共 49 条
  • [1] Breton S, 2001, JOP, V2, P159
  • [2] Genome-wide analysis of estrogen receptor binding sites
    Carroll, Jason S.
    Meyer, Clifford A.
    Song, Jun
    Li, Wei
    Geistlinger, Timothy R.
    Eeckhoute, Jerome
    Brodsky, Alexander S.
    Keeton, Erika Krasnickas
    Fertuck, Kirsten C.
    Hall, Giles F.
    Wang, Qianben
    Bekiranov, Stefan
    Sementchenko, Victor
    Fox, Edward A.
    Silver, Pamela A.
    Gingeras, Thomas R.
    Liu, X. Shirley
    Brown, Myles
    [J]. NATURE GENETICS, 2006, 38 (11) : 1289 - 1297
  • [3] Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
    Carroll, JS
    Liu, XS
    Brodsky, AS
    Li, W
    Meyer, CA
    Szary, AJ
    Eeckhoute, J
    Shao, WL
    Hestermann, EV
    Geistlinger, TR
    Fox, EA
    Silver, PA
    Brown, M
    [J]. CELL, 2005, 122 (01) : 33 - 43
  • [4] Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors
    Creighton, Chad J.
    Cordero, Kevin E.
    Larios, Jose M.
    Miller, Rebecca S.
    D Johnson, Michael
    Chinnaiyan, Arul M.
    Lippman, Marc E.
    Rae, James M.
    [J]. GENOME BIOLOGY, 2006, 7 (04)
  • [5] Regulation of GREB1 transcription by estrogen receptor α through a multipartite enhancer spread over 20 kb of upstream flanking sequences
    Deschenes, Julie
    Bourdeau, Veronique
    White, John H.
    Mader, Sylvie
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (24) : 17335 - 17339
  • [6] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
    Fisher, B
    Costantino, JP
    Wickerham, DL
    Redmond, CK
    Kavanah, M
    Cronin, WM
    Vogel, V
    Robidoux, A
    Dimitrov, N
    Atkins, J
    Daly, M
    Wieand, S
    Tan-Chiu, E
    Ford, L
    Wolmark, N
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) : 1371 - 1388
  • [7] Selective estrogen receptor modulators:: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells
    Frasor, J
    Stossi, F
    Danes, JM
    Komm, B
    Lyttle, CR
    Katzenellenbogen, BS
    [J]. CANCER RESEARCH, 2004, 64 (04) : 1522 - 1533
  • [8] Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype
    Frasor, J
    Danes, JM
    Komm, B
    Chang, KCN
    Lyttle, CR
    Katzenellenbogen, BS
    [J]. ENDOCRINOLOGY, 2003, 144 (10) : 4562 - 4574
  • [9] Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome
    Frasor, Jonna
    Chang, Edmund C.
    Komm, Barry
    Lin, Chin-Yo
    Vega, Vinsensius B.
    Liu, Edison T.
    Miller, Lance D.
    Smeds, Johanna
    Bergh, Jonas
    Katzenellenbogen, Benita S.
    [J]. CANCER RESEARCH, 2006, 66 (14) : 7334 - 7340
  • [10] Hypoxia-induced pathways in breast cancer
    Goonewardene, TI
    Sowter, HM
    Harris, AL
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (01) : 41 - 48